Form 4 for CRM Salesforce
Accepted 2024-09-23 00:00:00 ET · period of report 2024-09-22 · accession 0001127602-24-024324 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-23 | 2024-09-23 | CRM | Millham Brian | Pres, COO | S - Sale+OE | $266.22 | -5,735 | 4,856 | -54% | -$1.53M |
| DM | 2024-09-23 | 2024-09-22+ | CRM | Millham Brian | Pres, COO | M - OptEx | $110.07 | +7,398 | 5,719 | New | +$814.3K |
| DM | 2024-09-23 | 2024-09-22+ | CRM | Millham Brian | Pres, COO | M - OptEx | $0.00 | -7,398 | 61.1K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-23 | S | D | 858 | $264.78 | 1,663 | D | — | — | |
| 2 | Common | Common Stock | 2024-09-23 | M | A | 2,038 | $186.51 | 3,701 | D | — | — | |
| 3 | Common | Common Stock | 2024-09-23 | S | D | 821 | $264.78 | 2,521 | D | — | — | |
| 4 | Common | Common Stock | 2024-09-22 | M | A | 1,707 | $0.00 | 3,342 | D | — | — | |
| 5 | Common | Common Stock | 2024-09-22 | M | A | 1,635 | $0.00 | 1,635 | D | — | — | |
| 6 | Common | Common Stock | 2024-09-23 | M | A | 2,018 | $215.17 | 5,719 | D | — | — | |
| 7 | Common | Common Stock | 2024-09-23 | S | D | 197 | $267.75 | 1,663 | D | — | — | (F5) Weighted average price. These shares were sold in multiple transactions at prices ranging from $267.7300 to $267.7700 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| 8 | Common | Common Stock | 2024-09-23 | S | D | 2,996 | $267.17 | 1,860 | D | — | — | (F4) Weighted average price. These shares were sold in multiple transactions at prices ranging from $266.3700 to $267.2500 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| 9 | Common | Common Stock | 2024-09-23 | S | D | 863 | $265.36 | 4,856 | D | — | — | (F3) Weighted average price. These shares were sold in multiple transactions at prices ranging from $264.9900 to $265.7200 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| 10 | Derivative | Restricted Stock Units | 2024-09-22 | M | D | 1,635 | $0.00 | 3,269 | D | $0.00 · 2022-03-22 to 2025-03-22 | 1,635 Common Stock | (F6) Restricted Stock Units convert to shares of common stock on a one-for-one basis. (F7) These restricted stock units vest as to 25% of the original grant on March 22, 2022, and vest as to 1/16 of the original grant quarterly thereafter. |
| 11 | Derivative | Restricted Stock Units | 2024-09-22 | M | D | 1,707 | $0.00 | 10,239 | D | $0.00 · 2023-03-22 to 2026-03-22 | 1,707 Common Stock | (F6) Restricted Stock Units convert to shares of common stock on a one-for-one basis. (F8) These restricted stock units vest as to 25% of the original grant on March 22, 2023, and vest as to 1/16 of the original grant quarterly thereafter. |
| 12 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-09-23 | M | D | 2,018 | $0.00 | 12,107 | D | $215.17 · 2022-03-22 to 2028-03-22 | 2,018 Common Stock | (F10) Option is exercisable and vests over four years at the rate of 25% on March 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |
| 13 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-09-23 | M | D | 2,038 | $0.00 | 61,132 | D | $186.51 · 2024-03-22 to 2030-03-22 | 2,038 Common Stock | (F9) Option is exercisable and vests over four years at the rate of 25% on March 22, 2024, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |